Hongjuan Lu
415 Fengyang Road
Shanghai, 200003, China
Shanghai, 200003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Early divergence of treatment response trajectories to adalimumab or its biosimilar in active ankylosing spondylitis: consensus clustering analysis of a randomized controlled trial.
Journal: Frontiers in immunology
Published: February 05, 2026
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis.
Journal: Cell
Published: December 12, 2023
Identification of potent target and its mechanism of action of Tripterygium wilfordii Hook F in the treatment of lupus nephritis.
Journal: International journal of rheumatic diseases
Published: February 19, 2023
The correlations between C-reactive protein and MRI-detected inflammation in patients with axial spondyloarthritis: a systematic review and meta-analysis.
Journal: Clinical rheumatology
Published: June 07, 2022
Post-traumatic stress disorder in patients with rheumatic disease during the COVID-19 outbreak: a cross-sectional case-control study in China.
Journal: BMJ open
Published: March 31, 2022
Andersson Lesion in Ankylosing Spondylitis.
Journal: Rheumatology and immunology research
Published: November 21, 2021
Assessment of Neuropathic Pain in Ankylosing Spondylitis: Prevalence and Characteristics.
Journal: Pain and therapy
Published: June 30, 2021
Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation.
Journal: Frontiers in pharmacology
Published: April 09, 2021
Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis.
Journal: Frontiers of medicine
Published: December 18, 2017
IL-2 inhibited the generation of CD4+ memory T cells.
Journal: Cell biochemistry and biophysics
Published: July 04, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026